top of page

Adam Esposito, MBA Candidate


Adam spent 8 years at Moderna where he worked cross functionally within many departments including Research and Development, Preclinical Production, Oncology, Investor Relations, and Business Development. He has expertise in Formulations, Drug Delivery, and Analytics. Adam has contributed to several projects for SpikeVax™ (Moderna’s COVID-19 Vaccine) as well as other late-stage clinical assets.

He joined Moderna in 2014 when the company had 50 people as a Series C startup. He is currently pursuing his MBA from Harvard Business School where he was awarded the Kaplan Fellowship in Life Sciences.Adam holds a B.S. in Chemistry from Boston College with Honors. Adam is driven to make an impact in this space of immense unmet medical need based on his family’s experience with neurological diseases. He has published his work in Nature Communications and Protein Science.

Adam Esposito, MBA Candidate
bottom of page